Menu
  • Join
  • Login
  • Contact
 

Search abstracts


Interchangeability of biosimilars - yes or no?

  • At: 2014 FIP Congress in PSWC, Melbourne (Australia)
  • Type: Presentation
  • By: ROGER, Simon (Renal Research, Gosford, Australia)
  • Abstract:

    The advent of biosimilars has followed the expiration of patents covering biopharmaceuticals, providing opportunities for pharmaceutical companies to develop, produce and market these biosimilars or follow-on biologicals. Switching patients from one product to a similar but [quotright]not quite identical[quotrightB]product may have important

    ..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses